Compounds > arsenic trioxide
Page last updated: 2024-08-21

arsenic trioxide and paclitaxel

arsenic trioxide has been researched along with paclitaxel in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (52.17)29.6817
2010's8 (34.78)24.3611
2020's3 (13.04)2.80

Authors

AuthorsStudies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Cohen, MH; Flamm Honig, S; Hirschfeld, S; Ibrahim, A; Johnson, JR; O'Leary, JJ; Pazdur, R; White, RM; Williams, GA1
André, N; Braguer, D; Briand, C; Carles, G; Carré, M; Ciccolini, J; Douillard, S1
Holland, JF; Jiang, JD; Ling, YH; Perez-Soler, R1
Akay, C; Gazitt, Y; Thomas, C1
Ji, L; Li, X; Wang, Z1
Jing, Y; Waxman, S; Wurmbach, E; Xia, L1
Guo, W; Tang, S; Tang, XD; Yang, Y1
Ge, J; Huang, Y; Li, W; Liu, H; Liu, X; Qu, X; Sun, A; Yang, W; Zhao, K; Zou, Y1
Aldape, K; Aoki, H; Bogler, O; Conrad, C; Hess, K; Hollingsworth, EF; Iwado, E; Kobayashi, R; Kondo, S; Kondo, Y; Mills, G; Sawaya, R; Shingu, T; Shinojima, N; Tamada, Y; Yamamoto, A; Yokoyama, T; Zhang, L1
Wu, YC; Yen, WY; Yih, LH1
Dai, W; Duan, Q; Komissarova, E1
Chung, WH; Kim, SS; Kuh, HJ; Rhim, H; Sung, BH1
Chen, GQ; Duan, XF; Wang, XD; Wu, YL; Xu, HZ; Yan, H; Zhao, M; Zhuang, HY1
Dimov, IK; Ducrée, J; Kang, T; Kijanka, G; Lee, LP; Park, Y1
Chan, SY; Ho, PC; Ong, PS1
Armat, M; Bakhshaiesh, TO; Baradaran, B; Hejazi, MS; Samadi, N; Shanehbandi, D; Sharifi, S1
Asik, A; Balcı Okcanoglu, T; Biray Avci, C; Dogan Sigva, ZO; Gunduz, C; Kayabasi, C; Ozmen Yelken, B; Saydam, G; Yılmaz Susluer, S1
Chen, XJ; Fan, XD; Li, FZ; Piao, JG; Wang, BH; Wei, YH; Zhang, BB; Zheng, HS; Zheng, HY; Zhu, JJ1
Dion, GR; Jacobsen, C; Johnson, CM; Luke, AS; Novak, N1
He, ZY; Li, DC; Li, HY; Li, SJ; Liang, ZZ; Yan, J1

Reviews

3 review(s) available for arsenic trioxide and paclitaxel

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Advances in the study on the effects of Chinese herbal drugs on apoptosis].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2002, Volume: 25, Issue:2

    Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Drugs, Chinese Herbal; Humans; Materia Medica; Oxides; Paclitaxel; Plants, Medicinal; Quercetin; Sesquiterpenes; Tumor Cells, Cultured

2002
State of the Science in Tracheal Stents: A Scoping Review.
    The Laryngoscope, 2022, Volume: 132, Issue:11

    Topics: Adult; Alloys; Animals; Arsenic Trioxide; Cats; Dogs; Doxycycline; Humans; Magnesium; Mice; Mitomycin; Paclitaxel; Polydioxanone; Polyesters; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polytetrafluoroethylene; Polyurethanes; Rats; Sheep; Silicones; Sirolimus; Steel; Stents; Swine; Tracheal Stenosis

2022

Trials

1 trial(s) available for arsenic trioxide and paclitaxel

ArticleYear
A prospective trial to evaluate the clinical efficacy and safety of neoadjuvant chemotherapy with arsenic trioxide and carboplatin in locally advanced cervical cancer: a study protocol for randomized controlled clinical.
    Trials, 2022, Jul-08, Volume: 23, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Carboplatin; Chemotherapy, Adjuvant; Female; Humans; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Platinum; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome; Uterine Cervical Neoplasms

2022

Other Studies

19 other study(ies) available for arsenic trioxide and paclitaxel

ArticleYear
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Drug approval summaries: arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexarotene.
    The oncologist, 2001, Volume: 6, Issue:1

    Topics: Anastrozole; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Arsenic Trioxide; Arsenicals; Bexarotene; Breast Neoplasms; Drug Approval; Female; Humans; Leukemia, Promyelocytic, Acute; Lymphoma, T-Cell, Cutaneous; Nitriles; Oxides; Paclitaxel; Tamoxifen; Tetrahydronaphthalenes; Triazoles; United States; United States Food and Drug Administration

2001
Involvement of microtubules and mitochondria in the antagonism of arsenic trioxide on paclitaxel-induced apoptosis.
    Biochemical pharmacology, 2002, May-15, Volume: 63, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Division; Drug Antagonism; Humans; Microtubules; Mitochondria; Oxides; Paclitaxel; Tumor Cells, Cultured

2002
Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
    Molecular pharmacology, 2002, Volume: 62, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; CDC2 Protein Kinase; Cell Cycle; Cell Division; Cyclin B; Drug Resistance, Neoplasm; Humans; Microtubules; Mitosis; Oxides; Paclitaxel; Phosphorylation; Polymers; Proto-Oncogene Proteins c-bcl-2; Tubulin; Tumor Cells, Cultured

2002
Arsenic trioxide and paclitaxel induce apoptosis by different mechanisms.
    Cell cycle (Georgetown, Tex.), 2004, Volume: 3, Issue:3

    Topics: Apoptosis; Apoptosis Inducing Factor; Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; BH3 Interacting Domain Death Agonist Protein; Carrier Proteins; Caspases; Cell Line; Cell Nucleus; Chromatin; Cytochromes c; Enzyme Activation; Flavoproteins; Flow Cytometry; Gene Expression Regulation; Humans; Intracellular Membranes; Membrane Glycoproteins; Membrane Proteins; Mitochondria; Oxides; Paclitaxel; Phosphoserine; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha

2004
Upregulation of Bfl-1/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis.
    Leukemia, 2006, Volume: 20, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Gene Silencing; HL-60 Cells; Humans; Leukemia; Minor Histocompatibility Antigens; Oxides; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Tretinoin; Up-Regulation

2006
[Preliminary report of combination chemotherapy including Arsenic trioxide for stage III osteosarcoma and Ewing sarcoma].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2006, Jun-15, Volume: 44, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Neoplasms; Child; Etoposide; Female; Follow-Up Studies; Humans; Male; Osteosarcoma; Oxides; Paclitaxel; Sarcoma, Ewing; Treatment Outcome

2006
Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
    Cardiovascular research, 2006, Dec-01, Volume: 72, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Arsenic Trioxide; Arsenicals; Blood Vessel Prosthesis Implantation; Cell Cycle; Cell Proliferation; Coated Materials, Biocompatible; Flow Cytometry; Growth Inhibitors; Hyperplasia; Iliac Artery; Male; Microscopy, Electron, Scanning; Models, Animal; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxides; Paclitaxel; Rabbits; Stents; Tunica Intima

2006
Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3.
    Autophagy, 2008, Volume: 4, Issue:4

    Topics: Animals; Antibodies; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Autophagy; Cell Line, Tumor; Ceramides; Dacarbazine; Female; Glioblastoma; Humans; Mice; Mice, Nude; Microtubule-Associated Proteins; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Oxides; Paclitaxel; Phagosomes; Survival Rate; Temozolomide; Transplantation, Heterologous; Tubulin Modulators

2008
Requirement of a functional spindle checkpoint for arsenite-induced apoptosis.
    Journal of cellular biochemistry, 2008, Oct-15, Volume: 105, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Fibroblasts; HeLa Cells; Humans; Mitosis; Oxides; Paclitaxel; Spindle Apparatus; Tumor Suppressor Protein p53

2008
Arsenic trioxide suppresses paclitaxel-induced mitotic arrest.
    Cell proliferation, 2009, Volume: 42, Issue:3

    Topics: Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Line; Flow Cytometry; Humans; Microscopy, Fluorescence; Mitosis; Oxides; Paclitaxel

2009
Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro.
    International journal of oncology, 2009, Volume: 34, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Cisplatin; Drug Interactions; Drug Synergism; Female; Fluorouracil; Head and Neck Neoplasms; Humans; In Vitro Techniques; Inhibitory Concentration 50; Oxides; Paclitaxel; Poly(ADP-ribose) Polymerases; Stomach Neoplasms; Tubulin; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms

2009
Synergistic mitosis-arresting effects of arsenic trioxide and paclitaxel on human malignant lymphocytes.
    Chemico-biological interactions, 2010, Jan-05, Volume: 183, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; CDC2 Protein Kinase; Cells, Cultured; Drug Synergism; Humans; Jurkat Cells; Mitosis; Oxides; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tubulin Modulators

2010
Integrated microfluidic array plate (iMAP) for cellular and molecular analysis.
    Lab on a chip, 2011, Aug-21, Volume: 11, Issue:16

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Estrogen Receptor alpha; Fluorescent Antibody Technique; Gene Expression; HeLa Cells; Humans; Microfluidic Analytical Techniques; Oxides; Paclitaxel; Self-Sustained Sequence Replication; Structure-Activity Relationship

2011
Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2012, Feb-14, Volume: 45, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Expression Profiling; Humans; Interleukin-1alpha; NF-E2-Related Factor 2; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Oxides; Paclitaxel

2012
Arsenic Trioxide Promotes Paclitaxel Cytotoxicity in Resistant Breast Cancer Cells.
    Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Breast Neoplasms; Cell Proliferation; Drug Resistance, Neoplasm; Female; Humans; Oxides; Paclitaxel; Phosphoprotein Phosphatases; Protein Phosphatase 2C; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2015
Antileukemic effect of paclitaxel in combination with metformin in HL-60 cell line.
    Gene, 2018, Mar-20, Volume: 647

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Drug Therapy, Combination; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Metformin; NF-kappa B; Oxides; Paclitaxel; Signal Transduction

2018
Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.
    Acta pharmacologica Sinica, 2021, Volume: 42, Issue:5

    Topics: Acrylic Resins; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Breast Neoplasms; Cell Proliferation; Cetrimonium; Drug Carriers; Drug Liberation; Female; G2 Phase Cell Cycle Checkpoints; Human Umbilical Vein Endothelial Cells; Humans; MCF-7 Cells; Mice, Inbred ICR; Nanoparticles; Oligopeptides; Paclitaxel; Porosity; Silicon Dioxide; Xenograft Model Antitumor Assays

2021